Reply to: ‘Long‐term prognosis with or without nucleot(s)ide analogue therapy in hepatitis B virus‐related decompensated cirrhosis’
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Viral Hepatitis"
DOI: 10.1111/jvh.13514
Abstract: Thank you for the comments by Professor Weng on our article “Longterm prognosis with or without nucleot(s)ide analogue therapy in hepatitis B virusrelated decompensated cirrhosis”.1 I generally agree with his points. Our original study used… read more here.
Keywords: nonna group; nucleot ide; hepatitis; group ... See more keywords
Efficacy of Nucleot(s)ide Analogs Therapy in Patients with Unresectable HBV-Related Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
Sign Up to like & getrecommendations! Published in 2017 at "Disease Markers"
DOI: 10.1155/2017/7075935
Abstract: Aim. To determine whether nucleot(s)ide analogs therapy has survival benefit for patients with HBV-related HCC after unresectable treatment. Method. A systematic search was conducted through seven electronic databases including PubMed, OVID, EMBASE, Cochrane Databases, Elsevier,… read more here.
Keywords: nucleot ide; hbv related; group; analogs therapy ... See more keywords